Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coiled-coil domain containing protein 11 (CCDC11) is a cytoplasmic structural protein characterized by the presence of a coiled-coil domain, a motif broadly involved in protein-protein interactions, scaffolding, and cellular organization[1][2][7]. CCDC11 is required for proper ciliogenesis (the formation and maintenance of cilia) and plays a role in left-right axis specification during embryonic development. Variations in CCDC11 have been associated with congenital laterality disorders in humans. However, it is not currently considered a therapeutic target, and its direct involvement in major disease categories (such as cancer or cardiovascular disease) is not established. CCDC proteins, as a family, are diverse and can mediate various structural or regulatory cell functions, but individual members—including CCDC11—typically have specialized and less well-characterized functions compared to classical drug targets[2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil domain containing protein 11 (CCDC11).